1. Beta blockers and lipid levels

   Newsletter Article 05 February 2013 Pages: 2 - 3

2. Birth defects with isotretinoin therapy

   Newsletter Article 05 February 2013 Pages: 3 - 3

3. ACE inhibitor

   Newsletter Article 05 February 2013 Pages: 3 - 3

4. ACE inhibitors

   Newsletter Article 05 February 2013 Pages: 3 - 3

5. Ajmaline

   Newsletter Article 05 February 2013 Pages: 3 - 4

6. Alteplase/streptokinase/urokinase

   Newsletter Article 05 February 2013 Pages: 4 - 4

7. Aluminium

   Newsletter Article 05 February 2013 Pages: 4 - 4

8. Amiodarone

   Newsletter Article 05 February 2013 Pages: 4 - 4

9. Antipsychotics see Lithium interaction

   Newsletter Article 05 February 2013 Pages: 4 - 4

10. Atenolol

    Newsletter Article 05 February 2013 Pages: 4 - 4

11. Beta agonists

    Newsletter Article 05 February 2013 Pages: 4 - 4

12. Beta blockers see Phenelzine interaction

    Newsletter Article 05 February 2013 Pages: 4 - 4

13. Bleomycin

    Newsletter Article 05 February 2013 Pages: 4 - 5

14. Carbamazepine

    Newsletter Article 05 February 2013 Pages: 5 - 5

15. Chloroquine overdose

    Newsletter Article 05 February 2013 Pages: 5 - 5

16. Erythromycin

    Newsletter Article 05 February 2013 Pages: 5 - 5

17. Fluoxetine see Lithium interaction

    Newsletter Article 05 February 2013 Pages: 5 - 5

18. Heparin

    Newsletter Article 05 February 2013 Pages: 5 - 5

19. Iron dextran

    Newsletter Article 05 February 2013 Pages: 6 - 6

20. Isotretinoin

    Newsletter Article 05 February 2013 Pages: 6 - 6

21. Levomepromazine overdose

    Newsletter Article 05 February 2013 Pages: 6 - 6

22. Lithium interaction

    Newsletter Article 05 February 2013 Pages: 6 - 6

23. Lorazepam withdrawal

    Newsletter Article 05 February 2013 Pages: 6 - 7

24. Methyldopa

    Newsletter Article 05 February 2013 Pages: 7 - 7

25. Metoclopramide

    Newsletter Article 05 February 2013 Pages: 7 - 7

26. Mianserin

    Newsletter Article 05 February 2013 Pages: 7 - 7

27. Pentamidine

    Newsletter Article 05 February 2013 Pages: 7 - 7

28. Pergolide withdrawal

    Newsletter Article 05 February 2013 Pages: 7 - 8

29. Phenelzine interaction

    Newsletter Article 05 February 2013 Pages: 8 - 8

30. Streptokinase see Alteplase/streptokinase/urokinase

    Newsletter Article 05 February 2013 Pages: 8 - 8

31. Theophylline overdose

    Newsletter Article 05 February 2013 Pages: 8 - 8

32. Urokinase see Alteplase/streptokinase/urokinase

    Newsletter Article 05 February 2013 Pages: 8 - 8

33. Adverse drug reactions associated with calcium antagonist therapy

    Newsletter Article 05 February 2013 Pages: 8 - 8